HIV Seropositivity
Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV).
Year introduced: 1988
PubMed search builder options
Subheadings:
Tree Number(s): C01.221.250.875.500, C01.221.812.640.400.500, C01.778.640.400.500, C01.925.782.815.616.400.500, C01.925.813.400.500, C12.100.937.640.400.500, C20.673.480.500
MeSH Unique ID: D006679
Entry Terms:
- HIV Seropositivities
- Seropositivities, HIV
- Seropositivity, HIV
- AIDS Seropositivity
- AIDS Seropositivities
- Seropositivities, AIDS
- Seropositivity, AIDS
- Anti-HIV Positivity
- Anti-HIV Positivities
- Anti HIV Positivity
- Positivities, Anti-HIV
- Positivity, Anti-HIV
- HIV Antibody Positivity
- Antibody Positivities, HIV
- Antibody Positivity, HIV
- HIV Antibody Positivities
- Positivities, HIV Antibody
- Positivity, HIV Antibody
- HIV Seroconversion
- HIV Seroconversions
- Seroconversion, HIV
- Seroconversions, HIV
- HTLV-III Seroconversion
- HTLV III Seroconversion
- HTLV-III Seroconversions
- Seroconversion, HTLV-III
- Seroconversions, HTLV-III
- AIDS Seroconversion
- AIDS Seroconversions
- Seroconversion, AIDS
- Seroconversions, AIDS
- HTLV-III Seropositivity
- HTLV-III Seropositivities
- HTLV III Seropositivity
- Seropositivities, HTLV-III
- Seropositivity, HTLV-III
Previous Indexing:
See Also: